Thilo Schroeder, Director at PMV Pharmaceuticals, Inc. (PMVP), sold 126,446 shares at $36.08 ($4.6M) on 2021-08-09, disclosed to the SEC on 2021-08-09.
Open-market sale of $4.6M PMVP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.38 | 26,871 | $978K | 21.4% |
| 2 | $36.38 | 26,871 | $978K | 21.4% |
| 3 | $36.70 | 8,740 | $321K | 7.0% |
| 4 | $36.61 | 19,700 | $721K | 15.8% |
| 5 | $36.94 | 200 | $7K | 0.2% |
| 6 | $35.14 | 13,259 |
| $466K |
| 10.2% |
| 7 | $35.14 | 13,259 | $466K | 10.2% |
| 8 | $36.08 | 8,623 | $311K | 6.8% |
| 9 | $36.08 | 8,623 | $311K | 6.8% |
| 10 | $36.64 | 300 | $11K | 0.2% |
| Total | $36.14 avg | 126,446 | $4.6M | 100% |
| Filing → |
| RVMD | BUY | 2022-07-26 | $5.0M | — | Filing → |
| RVMD | BUY | 2022-03-29 | $2.1M | — | Filing → |
| RVMD | BUY | 2022-03-24 | $11.0M | — | Filing → |